Form 4: Organon & Co. Director Shalini Sharp Reports Acquisition of Phantom Stock

Director Shalini Sharp reports acquiring phantom stock units in Organon & Co. through the company's Non-Employee Director Savings Plan.

Summary

• Shalini Sharp, a director of Organon & Co., filed a Form 4 disclosing changes in beneficial ownership.
• The report details the acquisition of 9,638.554 phantom stock units on June 7, 2024, under the Organon Non-Employee Director Savings Plan.
• These phantom stock units are economically equivalent to shares of Organon common stock and will be settled in cash upon termination of service as a director.
• The reported holdings include phantom stock acquired through dividend reinvestment transactions on June 15, 2023, September 14, 2023, December 14, 2023 and March 14, 2024.
• Following the reported transaction, Sharp beneficially owns 36,783.9 phantom stock units.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing. The acquisition of phantom stock is a positive sign, but it's not a major event that would significantly impact investor sentiment.

Positives

• The acquisition of phantom stock demonstrates the director's continued investment in the company's future.
• The dividend reinvestment transactions indicate a long-term commitment to Organon & Co.

Future Outlook

The phantom stock units will be settled in cash upon the director's termination of service, indicating a future cash outflow for the company.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• Shareholders are informed about changes in ownership by a company director.
• The future cash settlement of phantom stock units will impact the company's financials.

Key Dates